ADMA Biologics ADMA

$ 19.39 -0.28%

Quarterly report 2024-Q2
added 08-08-2024

ADMA Biologics Balance Sheet 2011-2024 | ADMA

Annual Balance Sheet ADMA Biologics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-40.5 M	-74.9 M	-43 M	37.4 M	58 M	21.5 M	-137 K	10.3 M	5.29 M	-16.8 M	-21.1 M	-8.57 M	9.81 M
Long Term Debt	9.78 M	10.7 M	7.46 M	93 M	83.2 M	44.1 M	43 M	14.1 M	15.7 M	9.67 M	5 M	3.88 M	-
Long Term Debt Current	1.04 M	905 K	591 K	366 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	99.5 M	86.9 M	59.5 M	58.2 M	16.9 M	18.7 M	11.4 M	6.75 M	4.31 M	-
Total Current Liabilities	49.8 M	39.3 M	30.4 M	19.9 M	14 M	9.63 M	9.44 M	11.2 M	4.22 M	4.2 M	3.66 M	1.82 M	-
Total Liabilities	194 M	196 M	135 M	119 M	101 M	69.1 M	67.7 M	28.1 M	22.9 M	16 M	10.4 M	6.13 M	9.82 K
Deferred Revenue	182 K	143 K	143 K	143 K	143 K	143 K	143 K	145 K	145 K	-	75.6 K	-	-
Retained Earnings	-506 M	-478 M	-412 M	-340 M	-265 M	-216 M	-151 M	-107 M	-87.4 M	-58.5 M	-52.6 M	-37.1 M	-140 K
Total Assets	329 M	348 M	276 M	208 M	127 M	88.9 M	108 M	23.7 M	23.7 M	32 M	32 M	15.6 M	8.51 K
Cash and Cash Equivalents	51.4 M	86.5 M	51.1 M	55.9 M	26.8 M	22.8 M	43.1 M	9.91 M	10.4 M	17.2 M	26.1 M	12.5 M	87.8 K
Book Value	135 M	152 M	141 M	88.2 M	26.2 M	19.8 M	40.3 M	-4.46 M	821 K	15.9 M	21.6 M	9.42 M	-1.31 K
Total Shareholders Equity	135 M	152 M	141 M	88.2 M	26.2 M	19.8 M	40.3 M	-4.46 M	821 K	6.01 M	21.6 M	9.42 M	-

All numbers in USD currency

Quarterly Balance Sheet ADMA Biologics

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	9.18 M	9.49 M	9.78 M	9.97 M	10.2 M	10.5 M	10.7 M	10.6 M	10.9 M	7.28 M	7.46 M	6.92 M	7.07 M	-	4.33 M	4.33 M	4.33 M	-	-	-	-	-	2.76 M	2.76 M	2.76 M	2.76 M	2.76 M	2.76 M	2.76 M	2.76 M	1.79 M	1.79 M	1.79 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	188 M	197 M	194 M	198 M	196 M	195 M	196 M	200 M	183 M	181 M	135 M	136 M	121 M	123 M	119 M	119 M	119 M	119 M	101 M	101 M	101 M	101 M	69.1 M	69.1 M	69.1 M	69.1 M	67.7 M	67.7 M	67.7 M	67.7 M	28.1 M	28.1 M	28.1 M	28.1 M	22.9 M	22.9 M	22.9 M	22.9 M	21 M	21 M	21 M	21.2 M	10.4 M	10.4 M	10.4 M	10.4 M	6.13 M	6.13 M	6.13 M	6.13 M	2.54 M	2.54 M	2.54 M	2.54 M
Deferred Revenue	1.13 M	1.12 M	182 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	143 K	-	143 K	143 K	143 K	-	143 K	-	-	-	143 K	-	-	-	145 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-456 M	-488 M	-506 M	-489 M	-491 M	-485 M	-478 M	-466 M	-451 M	-437 M	-412 M	-395 M	-378 M	-359 M	-340 M	-340 M	-340 M	-340 M	-265 M	-265 M	-265 M	-265 M	-216 M	-216 M	-216 M	-216 M	-151 M	-151 M	-151 M	-151 M	-107 M	-107 M	-107 M	-107 M	-87.4 M	-87.4 M	-87.4 M	-87.4 M	-69.4 M	-69.4 M	-69.4 M	-69.4 M	-52.6 M	-52.6 M	-52.6 M	-52.6 M	-37.1 M	-37.1 M	-37.1 M	-37.1 M	-29.8 M	-29.8 M	-29.8 M	-29.8 M
Total Assets	376 M	351 M	329 M	349 M	343 M	341 M	348 M	301 M	297 M	308 M	276 M	239 M	233 M	236 M	208 M	208 M	208 M	208 M	127 M	127 M	143 M	127 M	88.9 M	88.9 M	88.9 M	88.9 M	108 M	108 M	108 M	108 M	23.7 M	23.7 M	23.7 M	23.7 M	23.7 M	23.7 M	23.7 M	23.7 M	27 M	27 M	27 M	27.2 M	32 M	32 M	32 M	32 M	15.6 M	15.6 M	15.6 M	15.6 M	2.93 M	2.93 M	2.93 M	2.93 M
Cash and Cash Equivalents	88.2 M	45.3 M	51.4 M	74.2 M	62.5 M	69.2 M	86.5 M	34.9 M	52.4 M	69.5 M	51.1 M	34.4 M	42.4 M	62 M	55.9 M	55.9 M	55.9 M	55.9 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	22.8 M	22.8 M	22.8 M	43.1 M	43.1 M	43.1 M	43.1 M	9.91 M	9.91 M	9.91 M	9.91 M	10.4 M	10.4 M	10.4 M	10.4 M	17.2 M	17.2 M	17.2 M	17.2 M	26.1 M	26.1 M	26.1 M	26.1 M	12.5 M	12.5 M	12.5 M	12.5 M	87.8 K	87.8 K	87.8 K	87.8 K
Book Value	188 M	154 M	135 M	151 M	147 M	146 M	152 M	100 M	114 M	127 M	141 M	103 M	112 M	113 M	88.2 M	88.2 M	88.2 M	88.2 M	26.2 M	26.2 M	42.4 M	26.2 M	19.8 M	19.8 M	19.8 M	19.8 M	40.3 M	40.3 M	40.3 M	40.3 M	-4.46 M	-4.46 M	-4.46 M	-4.46 M	821 K	821 K	821 K	821 K	6.01 M	6.01 M	6.01 M	6.01 M	21.6 M	21.6 M	21.6 M	21.6 M	9.42 M	9.42 M	9.42 M	9.42 M	386 K	386 K	386 K	386 K
Total Shareholders Equity	188 M	154 M	135 M	151 M	147 M	146 M	152 M	100 M	114 M	127 M	141 M	103 M	112 M	113 M	88.2 M	88.2 M	88.2 M	88.2 M	26.2 M	26.2 M	26.2 M	26.2 M	19.8 M	19.8 M	19.8 M	19.8 M	40.3 M	40.3 M	40.3 M	40.3 M	-4.46 M	-4.46 M	-4.46 M	-4.46 M	821 K	821 K	821 K	821 K	6.01 M	6.01 M	6.01 M	6.01 M	21.6 M	21.6 M	21.6 M	21.6 M	9.42 M	9.42 M	9.42 M	9.42 M	386 K	386 K	386 K	386 K

All numbers in USD currency